APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vitamin K Antagonists (VKA)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vitamin K Antagonists (VKA) Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchVitamin K Antagonists (VKA) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vitamin K Antagonists (VKA) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Vitamin K Antagonists (VKA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vitamin K Antagonists (VKA) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Vitamin K Antagonists (VKA) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Vitamin K Antagonists (VKA) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vitamin K Antagonists (VKA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vitamin K Antagonists (VKA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vitamin K Antagonists (VKA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vitamin K Antagonists (VKA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vitamin K Antagonists (VKA) include Sanofi, Johnson & Johnson, Lilly, Pfizer, Bayer, AstraZeneca, The Medicines Company, Otsuka and Genentech (Roche), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vitamin K Antagonists (VKA), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vitamin K Antagonists (VKA), also provides the sales of main regions and countries. Of the upcoming market potential for Vitamin K Antagonists (VKA), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vitamin K Antagonists (VKA) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vitamin K Antagonists (VKA) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vitamin K Antagonists (VKA) sales, projected growth trends, production technology, application and end-user industry.

Vitamin K Antagonists (VKA) Segment by Company

Sanofi

Johnson & Johnson

Lilly

Pfizer

Bayer

AstraZeneca

The Medicines Company

Otsuka

Genentech (Roche)

Daiichi Sankyo

Bristol-Myers Squibb

Boehringer Ingelheim

Aspen

Vitamin K Antagonists (VKA) Segment by Type

Oral Vitamin K Antagonists

Injection Vitamin K Antagonists

Vitamin K Antagonists (VKA) Segment by Application

AF

ACS/MI

VTE

Others

Vitamin K Antagonists (VKA) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin K Antagonists (VKA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vitamin K Antagonists (VKA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin K Antagonists (VKA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vitamin K Antagonists (VKA) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vitamin K Antagonists (VKA) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vitamin K Antagonists (VKA) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Vitamin K Antagonists Major Manufacturers Table 3. Injection Vitamin K Antagonists Major Manufacturers Table 4. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. AF Major Manufacturers Table 6. ACS/MI Major Manufacturers Table 7. VTE Major Manufacturers Table 8. Others Major Manufacturers Table 9. Vitamin K Antagonists (VKA) Industry Trends Table 10. Vitamin K Antagonists (VKA) Industry Drivers Table 11. Vitamin K Antagonists (VKA) Industry Opportunities and Challenges Table 12. Vitamin K Antagonists (VKA) Industry Restraints Table 13. Global Vitamin K Antagonists (VKA) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Vitamin K Antagonists (VKA) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Vitamin K Antagonists (VKA) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2021-2026) Table 17. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2027-2032) Table 18. Global Vitamin K Antagonists (VKA) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Tons) Table 19. Global Vitamin K Antagonists (VKA) Sales by Region (2021-2026) & (W Tons) Table 20. Global Vitamin K Antagonists (VKA) Sales by Region (2027-2032) & (W Tons) Table 21. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2021-2026) Table 22. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2027-2032) Table 23. Global Vitamin K Antagonists (VKA) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Vitamin K Antagonists (VKA) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Vitamin K Antagonists (VKA) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Vitamin K Antagonists (VKA) Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Vitamin K Antagonists (VKA) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Vitamin K Antagonists (VKA) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Vitamin K Antagonists (VKA) Manufacturers, Product Type & Application Table 31. Global Vitamin K Antagonists (VKA) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Vitamin K Antagonists (VKA) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Vitamin K Antagonists (VKA) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Vitamin K Antagonists (VKA) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Vitamin K Antagonists (VKA) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2021-2026) Table 38. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2027-2032) Table 39. Global Vitamin K Antagonists (VKA) Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 40. Global Vitamin K Antagonists (VKA) Sales by Type (2021-2026) & (W Tons) Table 41. Global Vitamin K Antagonists (VKA) Sales by Type (2027-2032) & (W Tons) Table 42. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2021-2026) Table 43. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2027-2032) Table 44. Global Vitamin K Antagonists (VKA) Price by Type (2021-2026) & (US$/Ton) Table 45. Global Vitamin K Antagonists (VKA) Price by Type (2027-2032) & (US$/Ton) Table 46. Global Vitamin K Antagonists (VKA) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Vitamin K Antagonists (VKA) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Vitamin K Antagonists (VKA) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2021-2026) Table 50. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2027-2032) Table 51. Global Vitamin K Antagonists (VKA) Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 52. Global Vitamin K Antagonists (VKA) Sales by Application (2021-2026) & (W Tons) Table 53. Global Vitamin K Antagonists (VKA) Sales by Application (2027-2032) & (W Tons) Table 54. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2021-2026) Table 55. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2027-2032) Table 56. Global Vitamin K Antagonists (VKA) Price by Application (2021-2026) & (US$/Ton) Table 57. Global Vitamin K Antagonists (VKA) Price by Application (2027-2032) & (US$/Ton) Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Sanofi Vitamin K Antagonists (VKA) Product Portfolio Table 62. Sanofi Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Vitamin K Antagonists (VKA) Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Lilly Company Information Table 69. Lilly Business Overview Table 70. Lilly Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Lilly Vitamin K Antagonists (VKA) Product Portfolio Table 72. Lilly Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Pfizer Vitamin K Antagonists (VKA) Product Portfolio Table 77. Pfizer Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Bayer Vitamin K Antagonists (VKA) Product Portfolio Table 82. Bayer Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. AstraZeneca Vitamin K Antagonists (VKA) Product Portfolio Table 87. AstraZeneca Recent Development Table 88. The Medicines Company Company Information Table 89. The Medicines Company Business Overview Table 90. The Medicines Company Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. The Medicines Company Vitamin K Antagonists (VKA) Product Portfolio Table 92. The Medicines Company Recent Development Table 93. Otsuka Company Information Table 94. Otsuka Business Overview Table 95. Otsuka Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Otsuka Vitamin K Antagonists (VKA) Product Portfolio Table 97. Otsuka Recent Development Table 98. Genentech (Roche) Company Information Table 99. Genentech (Roche) Business Overview Table 100. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Genentech (Roche) Vitamin K Antagonists (VKA) Product Portfolio Table 102. Genentech (Roche) Recent Development Table 103. Daiichi Sankyo Company Information Table 104. Daiichi Sankyo Business Overview Table 105. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Daiichi Sankyo Vitamin K Antagonists (VKA) Product Portfolio Table 107. Daiichi Sankyo Recent Development Table 108. Bristol-Myers Squibb Company Information Table 109. Bristol-Myers Squibb Business Overview Table 110. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Portfolio Table 112. Bristol-Myers Squibb Recent Development Table 113. Boehringer Ingelheim Company Information Table 114. Boehringer Ingelheim Business Overview Table 115. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Portfolio Table 117. Boehringer Ingelheim Recent Development Table 118. Aspen Company Information Table 119. Aspen Business Overview Table 120. Aspen Vitamin K Antagonists (VKA) Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Aspen Vitamin K Antagonists (VKA) Product Portfolio Table 122. Aspen Recent Development Table 123. North America Vitamin K Antagonists (VKA) Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Vitamin K Antagonists (VKA) Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Vitamin K Antagonists (VKA) Sales by Type (2021-2026) & (W Tons) Table 126. North America Vitamin K Antagonists (VKA) Sales by Type (2027-2032) & (W Tons) Table 127. North America Vitamin K Antagonists (VKA) Sales Price by Type (2021-2026) & (US$/Ton) Table 128. North America Vitamin K Antagonists (VKA) Sales Price by Type (2027-2032) & (US$/Ton) Table 129. North America Vitamin K Antagonists (VKA) Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Vitamin K Antagonists (VKA) Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Vitamin K Antagonists (VKA) Sales by Application (2021-2026) & (W Tons) Table 132. North America Vitamin K Antagonists (VKA) Sales by Application (2027-2032) & (W Tons) Table 133. North America Vitamin K Antagonists (VKA) Sales Price by Application (2021-2026) & (US$/Ton) Table 134. North America Vitamin K Antagonists (VKA) Sales Price by Application (2027-2032) & (US$/Ton) Table 135. North America Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Vitamin K Antagonists (VKA) Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 139. North America Vitamin K Antagonists (VKA) Sales by Country (2021-2026) & (W Tons) Table 140. North America Vitamin K Antagonists (VKA) Sales by Country (2027-2032) & (W Tons) Table 141. North America Vitamin K Antagonists (VKA) Sales Price by Country (2021-2026) & (US$/Ton) Table 142. North America Vitamin K Antagonists (VKA) Sales Price by Country (2027-2032) & (US$/Ton) Table 143. United States Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 144. Canada Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 145. Europe Vitamin K Antagonists (VKA) Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Vitamin K Antagonists (VKA) Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Vitamin K Antagonists (VKA) Sales by Type (2021-2026) & (W Tons) Table 148. Europe Vitamin K Antagonists (VKA) Sales by Type (2027-2032) & (W Tons) Table 149. Europe Vitamin K Antagonists (VKA) Sales Price by Type (2021-2026) & (US$/Ton) Table 150. Europe Vitamin K Antagonists (VKA) Sales Price by Type (2027-2032) & (US$/Ton) Table 151. Europe Vitamin K Antagonists (VKA) Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Vitamin K Antagonists (VKA) Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Vitamin K Antagonists (VKA) Sales by Application (2021-2026) & (W Tons) Table 154. Europe Vitamin K Antagonists (VKA) Sales by Application (2027-2032) & (W Tons) Table 155. Europe Vitamin K Antagonists (VKA) Sales Price by Application (2021-2026) & (US$/Ton) Table 156. Europe Vitamin K Antagonists (VKA) Sales Price by Application (2027-2032) & (US$/Ton) Table 157. Europe Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Vitamin K Antagonists (VKA) Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 161. Europe Vitamin K Antagonists (VKA) Sales by Country (2021-2026) & (W Tons) Table 162. Europe Vitamin K Antagonists (VKA) Sales by Country (2027-2032) & (W Tons) Table 163. Europe Vitamin K Antagonists (VKA) Sales Price by Country (2021-2026) & (US$/Ton) Table 164. Europe Vitamin K Antagonists (VKA) Sales Price by Country (2027-2032) & (US$/Ton) Table 165. Germany Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 166. France Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 167. U.K. Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 168. Italy Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 169. Netherlands Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 170. Nordic Countries Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 171. China Vitamin K Antagonists (VKA) Revenue by Type (2021-2026) & (US$ Million) Table 172. China Vitamin K Antagonists (VKA) Revenue by Type (2027-2032) & (US$ Million) Table 173. China Vitamin K Antagonists (VKA) Sales by Type (2021-2026) & (W Tons) Table 174. China Vitamin K Antagonists (VKA) Sales by Type (2027-2032) & (W Tons) Table 175. China Vitamin K Antagonists (VKA) Sales Price by Type (2021-2026) & (US$/Ton) Table 176. China Vitamin K Antagonists (VKA) Sales Price by Type (2027-2032) & (US$/Ton) Table 177. China Vitamin K Antagonists (VKA) Revenue by Application (2021-2026) & (US$ Million) Table 178. China Vitamin K Antagonists (VKA) Revenue by Application (2027-2032) & (US$ Million) Table 179. China Vitamin K Antagonists (VKA) Sales by Application (2021-2026) & (W Tons) Table 180. China Vitamin K Antagonists (VKA) Sales by Application (2027-2032) & (W Tons) Table 181. China Vitamin K Antagonists (VKA) Sales Price by Application (2021-2026) & (US$/Ton) Table 182. China Vitamin K Antagonists (VKA) Sales Price by Application (2027-2032) & (US$/Ton) Table 183. Asia Vitamin K Antagonists (VKA) Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Vitamin K Antagonists (VKA) Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Vitamin K Antagonists (VKA) Sales by Type (2021-2026) & (W Tons) Table 186. Asia Vitamin K Antagonists (VKA) Sales by Type (2027-2032) & (W Tons) Table 187. Asia Vitamin K Antagonists (VKA) Sales Price by Type (2021-2026) & (US$/Ton) Table 188. Asia Vitamin K Antagonists (VKA) Sales Price by Type (2027-2032) & (US$/Ton) Table 189. Asia Vitamin K Antagonists (VKA) Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Vitamin K Antagonists (VKA) Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Vitamin K Antagonists (VKA) Sales by Application (2021-2026) & (W Tons) Table 192. Asia Vitamin K Antagonists (VKA) Sales by Application (2027-2032) & (W Tons) Table 193. Asia Vitamin K Antagonists (VKA) Sales Price by Application (2021-2026) & (US$/Ton) Table 194. Asia Vitamin K Antagonists (VKA) Sales Price by Application (2027-2032) & (US$/Ton) Table 195. Asia Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Vitamin K Antagonists (VKA) Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 199. Asia Vitamin K Antagonists (VKA) Sales by Country (2021-2026) & (W Tons) Table 200. Asia Vitamin K Antagonists (VKA) Sales by Country (2027-2032) & (W Tons) Table 201. Asia Vitamin K Antagonists (VKA) Sales Price by Country (2021-2026) & (US$/Ton) Table 202. Asia Vitamin K Antagonists (VKA) Sales Price by Country (2027-2032) & (US$/Ton) Table 203. Japan Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 204. South Korea Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 205. India Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 206. Australia Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 207. China Taiwan Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Vitamin K Antagonists (VKA) Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Vitamin K Antagonists (VKA) Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Vitamin K Antagonists (VKA) Sales by Type (2021-2026) & (W Tons) Table 212. SAMEA Vitamin K Antagonists (VKA) Sales by Type (2027-2032) & (W Tons) Table 213. SAMEA Vitamin K Antagonists (VKA) Sales Price by Type (2021-2026) & (US$/Ton) Table 214. SAMEA Vitamin K Antagonists (VKA) Sales Price by Type (2027-2032) & (US$/Ton) Table 215. SAMEA Vitamin K Antagonists (VKA) Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Vitamin K Antagonists (VKA) Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Vitamin K Antagonists (VKA) Sales by Application (2021-2026) & (W Tons) Table 218. SAMEA Vitamin K Antagonists (VKA) Sales by Application (2027-2032) & (W Tons) Table 219. SAMEA Vitamin K Antagonists (VKA) Sales Price by Application (2021-2026) & (US$/Ton) Table 220. SAMEA Vitamin K Antagonists (VKA) Sales Price by Application (2027-2032) & (US$/Ton) Table 221. SAMEA Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Vitamin K Antagonists (VKA) Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 225. SAMEA Vitamin K Antagonists (VKA) Sales by Country (2021-2026) & (W Tons) Table 226. SAMEA Vitamin K Antagonists (VKA) Sales by Country (2027-2032) & (W Tons) Table 227. SAMEA Vitamin K Antagonists (VKA) Sales Price by Country (2021-2026) & (US$/Ton) Table 228. SAMEA Vitamin K Antagonists (VKA) Sales Price by Country (2027-2032) & (US$/Ton) Table 229. Brazil Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 230. Argentina Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 231. Chile Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 232. Colombia Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 233. Peru Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 235. Israel Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 236. UAE Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 237. Turkey Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 238. Iran Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 239. Egypt Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Vitamin K Antagonists (VKA) Distributors List Table 243. Vitamin K Antagonists (VKA) Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Vitamin K Antagonists (VKA) Image Figure 2. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vitamin K Antagonists (VKA) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Vitamin K Antagonists Image Figure 5. Injection Vitamin K Antagonists Image Figure 6. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Vitamin K Antagonists (VKA) Market Size Share 2021 VS 2025 VS 2032 Figure 8. AF Image Figure 9. ACS/MI Image Figure 10. VTE Image Figure 11. Others Image Figure 12. Global Vitamin K Antagonists (VKA) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Vitamin K Antagonists (VKA) Revenue (2021-2032) & (US$ Million) Figure 14. Global Vitamin K Antagonists (VKA) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2021-2032) Figure 17. Global Vitamin K Antagonists (VKA) Sales (2021-2032) & (W Tons) Figure 18. Global Vitamin K Antagonists (VKA) Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 19. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Vitamin K Antagonists (VKA) Sales YoY (2021-2032) & (W Tons) Figure 21. Europe Vitamin K Antagonists (VKA) Sales YoY (2021-2032) & (W Tons) Figure 22. China Vitamin K Antagonists (VKA) Sales YoY (2021-2032) & (W Tons) Figure 23. Asia (Excluding China) Vitamin K Antagonists (VKA) Sales YoY (2021-2032) & (W Tons) Figure 24. South America, Middle East and Africa Vitamin K Antagonists (VKA) Sales YoY (2021-2032) & (W Tons) Figure 25. Global Vitamin K Antagonists (VKA) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Vitamin K Antagonists (VKA) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Vitamin K Antagonists (VKA) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2021-2032) Figure 31. Global Vitamin K Antagonists (VKA) Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 32. Global Vitamin K Antagonists (VKA) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2021-2032) Figure 34. Global Vitamin K Antagonists (VKA) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2021-2032) Figure 37. Global Vitamin K Antagonists (VKA) Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 38. Global Vitamin K Antagonists (VKA) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2021-2032) Figure 40. North America Vitamin K Antagonists (VKA) Revenue Share by Type (2021-2032) Figure 41. North America Vitamin K Antagonists (VKA) Sales Share by Type (2021-2032) Figure 42. North America Vitamin K Antagonists (VKA) Revenue Share by Application (2021-2032) Figure 43. North America Vitamin K Antagonists (VKA) Sales Share by Application (2021-2032) Figure 44. North America Vitamin K Antagonists (VKA) Revenue Share by Country (2021-2032) Figure 45. North America Vitamin K Antagonists (VKA) Sales Share by Country (2021-2032) Figure 46. Europe Vitamin K Antagonists (VKA) Revenue Share by Type (2021-2032) Figure 47. Europe Vitamin K Antagonists (VKA) Sales Share by Type (2021-2032) Figure 48. Europe Vitamin K Antagonists (VKA) Revenue Share by Application (2021-2032) Figure 49. Europe Vitamin K Antagonists (VKA) Sales Share by Application (2021-2032) Figure 50. Europe Vitamin K Antagonists (VKA) Revenue Share by Country (2021-2032) Figure 51. Europe Vitamin K Antagonists (VKA) Sales Share by Country (2021-2032) Figure 52. China Vitamin K Antagonists (VKA) Revenue Share by Type (2021-2032) Figure 53. China Vitamin K Antagonists (VKA) Sales Share by Type (2021-2032) Figure 54. China Vitamin K Antagonists (VKA) Revenue Share by Application (2021-2032) Figure 55. China Vitamin K Antagonists (VKA) Sales Share by Application (2021-2032) Figure 56. Asia Vitamin K Antagonists (VKA) Revenue Share by Type (2021-2032) Figure 57. Asia Vitamin K Antagonists (VKA) Sales Share by Type (2021-2032) Figure 58. Asia Vitamin K Antagonists (VKA) Revenue Share by Application (2021-2032) Figure 59. Asia Vitamin K Antagonists (VKA) Sales Share by Application (2021-2032) Figure 60. Asia Vitamin K Antagonists (VKA) Revenue Share by Country (2021-2032) Figure 61. Asia Vitamin K Antagonists (VKA) Sales Share by Country (2021-2032) Figure 62. SAMEA Vitamin K Antagonists (VKA) Revenue Share by Type (2021-2032) Figure 63. SAMEA Vitamin K Antagonists (VKA) Sales Share by Type (2021-2032) Figure 64. SAMEA Vitamin K Antagonists (VKA) Revenue Share by Application (2021-2032) Figure 65. SAMEA Vitamin K Antagonists (VKA) Sales Share by Application (2021-2032) Figure 66. SAMEA Vitamin K Antagonists (VKA) Revenue Share by Country (2021-2032) Figure 67. SAMEA Vitamin K Antagonists (VKA) Sales Share by Country (2021-2032) Figure 68. Vitamin K Antagonists (VKA) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Vitamin K Antagonists (VKA) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Vitamin K Antagonists
  • Injection Vitamin K Antagonists
Applications
  • AF
  • ACS/MI
  • VTE
  • Others
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Lilly
  • Pfizer
  • Bayer
  • AstraZeneca
  • The Medicines Company
  • Otsuka
  • Genentech (Roche)
  • Daiichi Sankyo
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Aspen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vitamin K Antagonists (VKA) Market by Type
  3. 1.2.1 Global Vitamin K Antagonists (VKA) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Vitamin K Antagonists
  5. 1.2.3 Injection Vitamin K Antagonists
  6. 1.3 Vitamin K Antagonists (VKA) Market by Application
  7. 1.3.1 Global Vitamin K Antagonists (VKA) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 AF
  9. 1.3.3 ACS/MI
  10. 1.3.4 VTE
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Vitamin K Antagonists (VKA) Market Dynamics
  1. 2.1 Vitamin K Antagonists (VKA) Industry Trends
  2. 2.2 Vitamin K Antagonists (VKA) Industry Drivers
  3. 2.3 Vitamin K Antagonists (VKA) Industry Opportunities and Challenges
  4. 2.4 Vitamin K Antagonists (VKA) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vitamin K Antagonists (VKA) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vitamin K Antagonists (VKA) Revenue by Region
  3. 3.2.1 Global Vitamin K Antagonists (VKA) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vitamin K Antagonists (VKA) Revenue by Region (2021-2026)
  5. 3.2.3 Global Vitamin K Antagonists (VKA) Revenue by Region (2027-2032)
  6. 3.2.4 Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vitamin K Antagonists (VKA) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vitamin K Antagonists (VKA) Sales by Region
  9. 3.4.1 Global Vitamin K Antagonists (VKA) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vitamin K Antagonists (VKA) Sales by Region (2021-2026)
  11. 3.4.3 Global Vitamin K Antagonists (VKA) Sales by Region (2027-2032)
  12. 3.4.4 Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vitamin K Antagonists (VKA) Revenue by Manufacturers
  2. 4.1.1 Global Vitamin K Antagonists (VKA) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vitamin K Antagonists (VKA) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vitamin K Antagonists (VKA) Sales by Manufacturers
  6. 4.2.1 Global Vitamin K Antagonists (VKA) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vitamin K Antagonists (VKA) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vitamin K Antagonists (VKA) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vitamin K Antagonists (VKA) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vitamin K Antagonists (VKA) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vitamin K Antagonists (VKA) Manufacturers, Product Type & Application
  13. 4.7 Global Vitamin K Antagonists (VKA) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vitamin K Antagonists (VKA) Market CR5 and HHI
  16. 4.8.2 2025 Vitamin K Antagonists (VKA) Tier 1, Tier 2, and Tier 3
5 Vitamin K Antagonists (VKA) Market by Type
  1. 5.1 Global Vitamin K Antagonists (VKA) Revenue by Type
  2. 5.1.1 Global Vitamin K Antagonists (VKA) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vitamin K Antagonists (VKA) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vitamin K Antagonists (VKA) Sales by Type
  6. 5.2.1 Global Vitamin K Antagonists (VKA) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vitamin K Antagonists (VKA) Sales by Type (2021-2032) & (W Tons)
  8. 5.2.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vitamin K Antagonists (VKA) Price by Type
6 Vitamin K Antagonists (VKA) Market by Application
  1. 6.1 Global Vitamin K Antagonists (VKA) Revenue by Application
  2. 6.1.1 Global Vitamin K Antagonists (VKA) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vitamin K Antagonists (VKA) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vitamin K Antagonists (VKA) Sales by Application
  6. 6.2.1 Global Vitamin K Antagonists (VKA) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vitamin K Antagonists (VKA) Sales by Application (2021-2032) & (W Tons)
  8. 6.2.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vitamin K Antagonists (VKA) Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Vitamin K Antagonists (VKA) Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Vitamin K Antagonists (VKA) Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Lilly
  14. 7.3.1 Lilly Company Information
  15. 7.3.2 Lilly Business Overview
  16. 7.3.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lilly Vitamin K Antagonists (VKA) Product Portfolio
  18. 7.3.5 Lilly Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Vitamin K Antagonists (VKA) Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Bayer
  26. 7.5.1 Bayer Company Information
  27. 7.5.2 Bayer Business Overview
  28. 7.5.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bayer Vitamin K Antagonists (VKA) Product Portfolio
  30. 7.5.5 Bayer Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Vitamin K Antagonists (VKA) Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 The Medicines Company
  38. 7.7.1 The Medicines Company Company Information
  39. 7.7.2 The Medicines Company Business Overview
  40. 7.7.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 The Medicines Company Vitamin K Antagonists (VKA) Product Portfolio
  42. 7.7.5 The Medicines Company Recent Developments
  43. 7.8 Otsuka
  44. 7.8.1 Otsuka Company Information
  45. 7.8.2 Otsuka Business Overview
  46. 7.8.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Otsuka Vitamin K Antagonists (VKA) Product Portfolio
  48. 7.8.5 Otsuka Recent Developments
  49. 7.9 Genentech (Roche)
  50. 7.9.1 Genentech (Roche) Company Information
  51. 7.9.2 Genentech (Roche) Business Overview
  52. 7.9.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Genentech (Roche) Vitamin K Antagonists (VKA) Product Portfolio
  54. 7.9.5 Genentech (Roche) Recent Developments
  55. 7.10 Daiichi Sankyo
  56. 7.10.1 Daiichi Sankyo Company Information
  57. 7.10.2 Daiichi Sankyo Business Overview
  58. 7.10.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Portfolio
  60. 7.10.5 Daiichi Sankyo Recent Developments
  61. 7.11 Bristol-Myers Squibb
  62. 7.11.1 Bristol-Myers Squibb Company Information
  63. 7.11.2 Bristol-Myers Squibb Business Overview
  64. 7.11.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Portfolio
  66. 7.11.5 Bristol-Myers Squibb Recent Developments
  67. 7.12 Boehringer Ingelheim
  68. 7.12.1 Boehringer Ingelheim Company Information
  69. 7.12.2 Boehringer Ingelheim Business Overview
  70. 7.12.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Portfolio
  72. 7.12.5 Boehringer Ingelheim Recent Developments
  73. 7.13 Aspen
  74. 7.13.1 Aspen Company Information
  75. 7.13.2 Aspen Business Overview
  76. 7.13.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Aspen Vitamin K Antagonists (VKA) Product Portfolio
  78. 7.13.5 Aspen Recent Developments
8 North America
  1. 8.1 North America Vitamin K Antagonists (VKA) Market Size by Type
  2. 8.1.1 North America Vitamin K Antagonists (VKA) Revenue by Type (2021-2032)
  3. 8.1.2 North America Vitamin K Antagonists (VKA) Sales by Type (2021-2032)
  4. 8.1.3 North America Vitamin K Antagonists (VKA) Price by Type (2021-2032)
  5. 8.2 North America Vitamin K Antagonists (VKA) Market Size by Application
  6. 8.2.1 North America Vitamin K Antagonists (VKA) Revenue by Application (2021-2032)
  7. 8.2.2 North America Vitamin K Antagonists (VKA) Sales by Application (2021-2032)
  8. 8.2.3 North America Vitamin K Antagonists (VKA) Price by Application (2021-2032)
  9. 8.3 North America Vitamin K Antagonists (VKA) Market Size by Country
  10. 8.3.1 North America Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vitamin K Antagonists (VKA) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vitamin K Antagonists (VKA) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Vitamin K Antagonists (VKA) Market Size by Type
  2. 9.1.1 Europe Vitamin K Antagonists (VKA) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vitamin K Antagonists (VKA) Sales by Type (2021-2032)
  4. 9.1.3 Europe Vitamin K Antagonists (VKA) Price by Type (2021-2032)
  5. 9.2 Europe Vitamin K Antagonists (VKA) Market Size by Application
  6. 9.2.1 Europe Vitamin K Antagonists (VKA) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vitamin K Antagonists (VKA) Sales by Application (2021-2032)
  8. 9.2.3 Europe Vitamin K Antagonists (VKA) Price by Application (2021-2032)
  9. 9.3 Europe Vitamin K Antagonists (VKA) Market Size by Country
  10. 9.3.1 Europe Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vitamin K Antagonists (VKA) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vitamin K Antagonists (VKA) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Vitamin K Antagonists (VKA) Market Size by Type
  2. 10.1.1 China Vitamin K Antagonists (VKA) Revenue by Type (2021-2032)
  3. 10.1.2 China Vitamin K Antagonists (VKA) Sales by Type (2021-2032)
  4. 10.1.3 China Vitamin K Antagonists (VKA) Price by Type (2021-2032)
  5. 10.2 China Vitamin K Antagonists (VKA) Market Size by Application
  6. 10.2.1 China Vitamin K Antagonists (VKA) Revenue by Application (2021-2032)
  7. 10.2.2 China Vitamin K Antagonists (VKA) Sales by Application (2021-2032)
  8. 10.2.3 China Vitamin K Antagonists (VKA) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vitamin K Antagonists (VKA) Market Size by Type
  2. 11.1.1 Asia Vitamin K Antagonists (VKA) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vitamin K Antagonists (VKA) Sales by Type (2021-2032)
  4. 11.1.3 Asia Vitamin K Antagonists (VKA) Price by Type (2021-2032)
  5. 11.2 Asia Vitamin K Antagonists (VKA) Market Size by Application
  6. 11.2.1 Asia Vitamin K Antagonists (VKA) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vitamin K Antagonists (VKA) Sales by Application (2021-2032)
  8. 11.2.3 Asia Vitamin K Antagonists (VKA) Price by Application (2021-2032)
  9. 11.3 Asia Vitamin K Antagonists (VKA) Market Size by Country
  10. 11.3.1 Asia Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vitamin K Antagonists (VKA) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vitamin K Antagonists (VKA) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vitamin K Antagonists (VKA) Market Size by Type
  2. 12.1.1 SAMEA Vitamin K Antagonists (VKA) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vitamin K Antagonists (VKA) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vitamin K Antagonists (VKA) Price by Type (2021-2032)
  5. 12.2 SAMEA Vitamin K Antagonists (VKA) Market Size by Application
  6. 12.2.1 SAMEA Vitamin K Antagonists (VKA) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vitamin K Antagonists (VKA) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vitamin K Antagonists (VKA) Price by Application (2021-2032)
  9. 12.3 SAMEA Vitamin K Antagonists (VKA) Market Size by Country
  10. 12.3.1 SAMEA Vitamin K Antagonists (VKA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vitamin K Antagonists (VKA) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vitamin K Antagonists (VKA) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vitamin K Antagonists (VKA) Value Chain Analysis
  2. 13.1.1 Vitamin K Antagonists (VKA) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vitamin K Antagonists (VKA) Production Mode & Process
  6. 13.2 Vitamin K Antagonists (VKA) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vitamin K Antagonists (VKA) Distributors
  9. 13.2.3 Vitamin K Antagonists (VKA) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst